Point of Care Testing Market Opportunities & Challenges 2025-2035

Published Date: Sep 2024 | Report ID: MI1010 | 210 Pages

Point of Care Testing Market By Product Type (Infectious Diseases Testing, Blood Glucose Monitoring, Cardiac Testing, Coagulation Testing, Fertility Testing, Drug Abuse Testing, Respiratory Testing, Others), By Sample Type (Blood Samples, Respiratory Samples, Urine Samples, Saliva Samples, Fecal Samples, Tissue Samples, Other) and By Technology (Immunoassays, Molecular Diagnostics, Electrochemical Detection, Optical Detection, Bio Sensors, Microfluidics, Imaging Technology, Wearable Technology, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Inquiry Before Buying

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Global Point of Care Testing Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Need for rapid diagnostic results to facilitate timely medical decisions and patient management

3.2.2. Technological innovations in POCT devices, including miniaturization, automation, and integration with digital platforms.

3.2.3. The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases

3.3. Key industry pitfalls & challenges

3.3.1. Ensuring the accuracy, reliability, and quality control of POCT devices can be challenging

3.3.2. Stringent regulatory requirements and approval processes for POCT devices across different regions

3.3.3. The initial cost of POCT devices and consumables, ongoing maintenance expenses

3.4. Market Opportunities

3.4.1. Rising disease burden in emerging markets

3.4.2. Integrating POCT devices with telemedicine platforms and remote monitoring solutions

3.4.3. Expanding the use of POCT devices beyond traditional healthcare settings to pharmacies, community health centers, workplaces

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Pipeline Analysis

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Point of Care Testing Market, Product Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Infectious Diseases Testing

4.2.1. Market Revenue Share, By Product, 2025 & 2035

4.3. Blood Glucose Monitoring

4.3.1. Market Revenue Share, By Product, 2025 & 2035

4.4. Cardiac Testing

4.4.1. Market Revenue Share, By Product, 2025 & 2035

4.5. Coagulation Testing

4.5.1. Market Revenue Share, By Product, 2025 & 2035

4.6. Fertility Testing

4.6.1. Market Revenue Share, By Product, 2025 & 2035

4.7. Drug Abuse Testing

4.7.1. Market Revenue Share, By Product, 2025 & 2035

4.8. Respiratory Testing 

4.8.1. Market Revenue Share, By Product, 2025 & 2035

4.9. Others

4.9.1. Market Revenue Share, By Product, 2025 & 2035

5. Point of Care Testing Market, Sample Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Sample Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Blood Samples

5.2.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.3. Respiratory Samples

5.3.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.4. Urine Samples

5.4.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.5. Saliva Samples

5.5.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.6. Fecal Samples

5.6.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.7. Tissue Samples

5.7.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

5.8. Others

5.8.1. Market Size and Forecast, By Sample Type, 2025-2035 (USD Million)

6. Point of Care Testing Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Immunoassays

6.2.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.3. Molecular Diagnostics

6.3.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.4. Electrochemical Detection

6.4.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.5. Optical Detection

6.5.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.6. Bio Sensors

6.6.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.7. Microfluidics

6.7.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.8. Imaging Technology

6.8.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.9. Wearable Technology

6.9.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

6.10. Others

6.10.1. Market Size and Forecast, By Technology, 2025-2035 (USD Million)

7. Point of Care Testing Market, Region Segment Analysis

7.1. Overview

7.1.1. Global Market Revenue Share, By Region, 2025 & 2035

7.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

7.2. North America

7.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

7.2.2. North America Market Revenue, By Product, 2025-2035

7.2.3. North America Market Revenue, By Sample Type, 2025-2035

7.2.4. North America Market Revenue, By Technology, 2025-2035

7.2.5. The U.S.

7.2.5.1. U.S. Market Revenue, By Product, 2025-2035

7.2.5.2. U.S. Market Revenue, By Sample Type, 2025-2035

7.2.5.3. U.S. Market Revenue, By Technology, 2025-2035

7.2.6. Canada

7.2.6.1. Canada Market Revenue, By Product, 2025-2035

7.2.6.2. Canada Market Revenue, By Sample Type, 2025-2035

7.2.6.3. Canada Market Revenue, By Technology, 2025-2035

7.3. Europe

7.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

7.3.2. Europe Market Revenue, By Product, 2025-2035

7.3.3. Europe Market Revenue, By Sample Type, 2025-2035

7.3.4. Europe Market Revenue, By Technology, 2025-2035

7.3.5. Germany

7.3.5.1. Germany Market Revenue, By Product, 2025-2035

7.3.5.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.5.3. Germany Market Revenue, By Technology, 2025-2035

7.3.6. France

7.3.6.1. Germany Market Revenue, By Product, 2025-2035

7.3.6.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.6.3. Germany Market Revenue, By Technology, 2025-2035

7.3.7. U.K.

7.3.7.1. Germany Market Revenue, By Product, 2025-2035

7.3.7.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.7.3. Germany Market Revenue, By Technology, 2025-2035

7.3.8. Italy

7.3.8.1. Germany Market Revenue, By Product, 2025-2035

7.3.8.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.8.3. Germany Market Revenue, By Technology, 2025-2035

7.3.9. Spain

7.3.9.1. Germany Market Revenue, By Product, 2025-2035

7.3.9.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.9.3. Germany Market Revenue, By Technology, 2025-2035

7.3.10. Rest of Europe

7.3.10.1. Germany Market Revenue, By Product, 2025-2035

7.3.10.2. Germany Market Revenue, By Sample Type, 2025-2035

7.3.10.3. Germany Market Revenue, By Technology, 2025-2035

7.4. Asia Pacific

7.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

7.4.2. Asia Pacific Market Revenue, By Product, 2025-2035

7.4.3. Asia Pacific Market Revenue, By Sample Type, 2025-2035

7.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

7.4.5. China

7.4.5.1. China Market Revenue, By Product, 2025-2035

7.4.5.2. China Market Revenue, By Sample Type, 2025-2035

7.4.5.3. Canada Market Revenue, By Technology, 2025-2035

7.4.6. Japan

7.4.6.1. Japan Market Revenue, By Product, 2025-2035

7.4.6.2. Japan Market Revenue, By Sample Type, 2025-2035

7.4.6.3. Japan Market Revenue, By Technology, 2025-2035

7.4.7. India

7.4.7.1. India Market Revenue, By Product, 2025-2035

7.4.7.2. India Pacific Market Revenue, By Sample Type, 2025-2035

7.4.7.3. India Pacific Market Revenue, By Technology, 2025-2035

7.4.8. Australia

7.4.8.1. Australia Market Revenue, By Product, 2025-2035

7.4.8.2. Australia Pacific Market Revenue, By Sample Type, 2025-2035

7.4.8.3. Australia Pacific Market Revenue, By Technology, 2025-2035

7.4.9. South Korea

7.4.9.1. South Korea Market Revenue, By Product, 2025-2035

7.4.9.2. South Korea Market Revenue, By Sample Type, 2025-2035

7.4.9.3. South Korea Market Revenue, By Technology, 2025-2035

7.4.10. Singapore

7.4.10.1. Singapore Market Revenue, By Product, 2025-2035

7.4.10.2. Singapore Market Revenue, By Sample Type, 2025-2035

7.4.10.3. Singapore Market Revenue, By Technology, 2025-2035

7.4.11. Rest of Asia Pacific

7.4.11.1. Rest of Asia Pacific Market Revenue, By Product, 2025-2035

7.4.11.2. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035

7.4.11.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

7.5. Latin America

7.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

7.5.2. Latin America Market Revenue, By Product, 2025-2035

7.5.3. Latin America Market Revenue, By Sample Type, 2025-2035

7.5.4. Latin America Market Revenue, By Technology, 2025-2035

7.5.5. Brazil

7.5.5.1. Brazil Market Revenue, By Product, 2025-2035

7.5.5.2. Brazil Market Revenue, By Sample Type, 2025-2035

7.5.5.3. Brazil Market Revenue, By Technology, 2025-2035

7.5.6. Argentina

7.5.6.1. Argentina Market Revenue, By Product, 2025-2035

7.5.6.2. Argentina Market Revenue, By Sample Type, 2025-2035

7.5.6.3. Argentina Market Revenue, By Technology, 2025-2035

7.5.7. Mexico

7.5.7.1. Mexico Market Revenue, By Product, 2025-2035

7.5.7.2. Mexico Market Revenue, By Sample Type, 2025-2035

7.5.7.3. Mexico Market Revenue, By Technology, 2025-2035

7.5.8. Rest of Latin America

7.5.8.1. Rest of Latin America Market Revenue, By Product, 2025-2035

7.5.8.2. Rest of Latin America Market Revenue, By Sample Type, 2025-2035

7.5.8.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

7.6. MEA

7.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

7.6.2. MEA Market Revenue, By Product, 2025-2035

7.6.3. MEA Market Revenue, By Sample Type, 2025-2035

7.6.4. MEA Market Revenue, By Technology, 2025-2035

7.6.5. GCC Countries

7.6.5.1. GCC Countries Market Revenue, By Product, 2025-2035

7.6.5.2. GCC Countries Market Revenue, By Sample Type, 2025-2035

7.6.5.3. GCC Countries Market Revenue, By Technology, 2025-2035

7.6.6. South Africa

7.6.6.1. South Africa Countries Market Revenue, By Product, 2025-2035

7.6.6.2. South Africa Countries Market Revenue, By Sample Type, 2025-2035

7.6.6.3. South Africa Countries Market Revenue, By Technology, 2025-2035

7.6.7. Rest of Middle-East Africa

7.6.7.1. Rest of Middle-East Africa Countries Market Revenue, By Product, 2025-2035

7.6.7.2. Rest of Middle-East Africa Countries Market Revenue, By Sample Type, 2025-2035

7.6.7.3. Rest of Middle-East Africa Countries Market Revenue, By Technology, 2025-2035

8. Company Profile

8.1. F. Hoffmann-La Roche Ltd.

8.1.1. Business Overview

8.1.2. Financial Performance

8.1.3. Product/Service Offerings

8.1.4. Strategies & recent developments

8.1.5. SWOT Analysis

8.2. Abbott Laboratories

8.2.1. Business Overview

8.2.2. Financial Performance

8.2.3. Product/Service Offerings

8.2.4. Strategies & recent developments

8.2.5. SWOT Analysis

8.3. Becton, Dickinson and Company (BD)

8.3.1. Business Overview

8.3.2. Financial Performance

8.3.3. Product/Service Offerings

8.3.4. Strategies & recent developments

8.3.5. SWOT Analysis

8.4. Danaher Corporation

8.4.1. Business Overview

8.4.2. Financial Performance

8.4.3. Product/Service Offerings

8.4.4. Strategies & recent developments

8.4.5. SWOT Analysis

8.5. Siemens Healthineers

8.5.1. Business Overview

8.5.2. Financial Performance

8.5.3. Product/Service Offerings

8.5.4. Strategies & recent developments

8.5.5. SWOT Analysis

8.6. Bio-Rad Laboratories Inc.

8.6.1. Business Overview

8.6.2. Financial Performance

8.6.3. Product/Service Offerings

8.6.4. Strategies & recent developments

8.6.5. SWOT Analysis

8.7. bioMérieux

8.7.1. Business Overview

8.7.2. Financial Performance

8.7.3. Product/Service Offerings

8.7.4. Strategies & recent developments

8.7.5. SWOT Analysis

8.8. Nova Biomedical

8.8.1. Business Overview

8.8.2. Financial Performance

8.8.3. Product/Service Offerings

8.8.4. Strategies & recent developments

8.8.5. SWOT Analysis

8.9. QuidelOrtho Corporation

8.9.1. Business Overview

8.9.2. Financial Performance

8.9.3. Product/Service Offerings

8.9.4. Strategies & recent developments

8.9.5. SWOT Analysis

8.10. Trinity Biotech

8.10.1. Business Overview

8.10.2. Financial Performance

8.10.3. Product/Service Offerings

8.10.4. Strategies & recent developments

8.10.5. SWOT Analysis

8.11. Sekisui Diagnostics

8.11.1. Business Overview

8.11.2. Financial Performance

8.11.3. Product/Service Offerings

8.11.4. Strategies & recent developments

8.11.5. SWOT Analysis

8.12. AccuBioTech Co., Ltd.

8.12.1. Business Overview

8.12.2. Financial Performance

8.12.3. Product/Service Offerings

8.12.4. Strategies & recent developments

8.12.5. SWOT Analysis

8.13. HemoCue AB (Danaher Corporation)

8.13.1. Business Overview

8.13.2. Financial Performance

8.13.3. Product/Service Offerings

8.13.4. Strategies & recent developments

8.13.5. SWOT Analysis

8.14. OraSure Technologies, Inc.

8.14.1. Business Overview

8.14.2. Financial Performance

8.14.3. Product/Service Offerings

8.14.4. Strategies & recent developments

8.14.5. SWOT Analysis

8.15. EKF Diagnostics Holdings plc.

8.15.1. Business Overview

8.15.2. Financial Performance

8.15.3. Product/Service Offerings

8.15.4. Strategies & recent developments

8.15.5. SWOT Analysis

8.16. Chembio Diagnostic Systems

8.16.1. Business Overview

8.16.2. Financial Performance

8.16.3. Product/Service Offerings

8.16.4. Strategies & recent developments

8.16.5. SWOT Analysis

8.17. Poc Diagnostics

8.17.1. Business Overview

8.17.2. Financial Performance

8.17.3. Product/Service Offerings

8.17.4. Strategies & recent developments

8.17.5. SWOT Analysis

8.18. Sysmex Corporation

8.18.1. Business Overview

8.18.2. Financial Performance

8.18.3. Product/Service Offerings

8.18.4. Strategies & recent developments

8.18.5. SWOT Analysis

8.19. BioLytical Laboratories Inc.

8.19.1. Business Overview

8.19.2. Financial Performance

8.19.3. Product/Service Offerings

8.19.4. Strategies & recent developments

8.19.5. SWOT Analysis

8.20. Meridian Bioscience

8.20.1. Business Overview

8.20.2. Financial Performance

8.20.3. Product/Service Offerings

8.20.4. Strategies & recent developments

8.20.5. SWOT Analysis

 

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.